Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesBreastDBT performance improves with patient ageDBT led to higher cancer detection rates and lower abnormal interpretation rates in older women in a study over 93,000 women.Digital X-RayAI fails to compensate for night-shift fatigue among residentsPractice ManagementTrainee-led informed consent talks with patients often insufficientCTHigh CAC scores nearly doubles 30-year mortality in young adultsSponsor ContentFREE webinar: find your imaging capacity